Sign in

CIK 0001799448

  • Non-accelerated filer
  • Smaller reporting company

Aligos Therapeutics, Inc.

Sign in to watch
Ticker
ALGS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 800-466-6059
Business address
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-10-20 Woiwode Thomas Director Conversion · Series A Preferred Stock −2,145,991 0
2020-10-20 Woiwode Thomas Director Conversion · Series B-1 Preferred Stock −198,839 0
2020-10-20 Woiwode Thomas Director Conversion · Series B-1 Preferred Stock −463,959 0
2020-10-20 Woiwode Thomas Director Conversion · Series B-2 Preferred Stock −85,065 0
2020-10-20 Woiwode Thomas Director Conversion · Series B-2 Preferred Stock −198,485 0

Page 2 of 2 · 25 trades